Hope For Successful Alzheimer’s Drug Comes After Compound Reverses The Disease In Mouse Models
Posted in: Today's ChiliResearchers at Saint Louis University have successfully reduced the
symptoms of Alzheimer’s in mice genetically engineered to have
Alzheimer’s disease (AD). The specific molecular compound that was used
in the study, antisense oligonucleotide (OL-1), attacked the most widely-studied cause of AD, the accumulation of amyloid beta protein in the brain.